Pine Labs Limited has invested ₹24,99,93,297 in Synergistic Financial Networks Private Limited (SFNPL) through a subscription to a rights issue to meet working capital needs and fund growth opportunities. The transaction involved the acquisition of 49,869 equity shares and was completed on June 29, 2026. As SFNPL is a wholly owned subsidiary, the investment does not alter Pine Labs' shareholding percentage in the entity.

The investment was made via cash consideration to support SFNPL's operations and its investments in step-down subsidiaries. SFNPL operates in the Financial Technology industry, facilitating financial transactions through systems infrastructure, payment processing, and technology-integrated solutions. The entity was incorporated on March 12, 2008, and maintains its presence in India.

Financial Details of SFNPL

Following the infusion of funds, the paid-up capital of SFNPL stands at ₹3,18,15,790. The subsidiary reported a turnover of ₹1,89,74,69,654 as of March 31, 2026. The transaction is not classified as a related party transaction, and no specific governmental or regulatory approvals were required for its completion.

Historical Turnover

SFNPL has demonstrated consistent operational activity over the past three years. The turnover figures for the last three financial years are detailed below:

The disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Pine Labs has received sustained bullish coverage from two major global brokerages, with both Citi and UBS maintaining Buy ratings on the stock. The two firms have outlined distinct but complementary investment theses, each pointing to robust revenue growth prospects and improving profitability metrics over the medium term.

Citi Maintains Buy with ₹235 Target Price

Citi has reaffirmed its Buy rating on Pine Labs, setting a target price of ₹235. The brokerage's positive stance is anchored in the company's FY27 growth guidance of 21–23%, which signals continued momentum in its core business operations. Citi also highlights improving B2B fintech monetisation as a key driver, alongside higher attach-rate opportunities spanning merchants, banks, and brands as structural growth enablers.

The following table summarises the key financial projections cited by Citi:

Citi's projections indicate a meaningful EBITDA margin expansion trajectory, rising from 21% in FY26 to 26% in FY27 and further to 30% in FY28. This margin improvement, combined with an expected 18.5% revenue CAGR, forms the backbone of Citi's constructive outlook on the stock.

UBS Maintains Buy with ₹220 Target Price

UBS has also maintained its Buy rating on Pine Labs, with a target price of ₹220. The brokerage's thesis centres on the company's strategic expansion into medium enterprises and emerging opportunities in government and OMC (Oil Marketing Company) point-of-sale segments. UBS points to strong affordability growth as a key highlight, with GMV reaching ₹740bn, reflecting a 22% YoY increase.

The table below captures the key parameters from UBS's coverage:

UBS also draws attention to several qualitative strengths underpinning its positive view:

• EMI-on-UPI rollout as an emerging product opportunity
• Differentiated merchant relationships and a robust technology stack
• AI transaction rails as a competitive differentiator
• Margin expansion expected alongside revenue growth over FY26–28

The brokerage's projection of a 19% revenue CAGR over FY26–28, coupled with guidance for 20%+ revenue growth, reflects confidence in Pine Labs' ability to scale across its target segments.

Convergent Bullish Outlook

Both Citi and UBS present a broadly aligned view on Pine Labs' growth trajectory, with revenue CAGR estimates of 18.5% and 19% respectively over comparable periods. While Citi focuses on B2B fintech monetisation and attach-rate expansion, UBS emphasises enterprise segment penetration, product innovation through EMI-on-UPI, and technology-led differentiation. Together, the two ratings reinforce a constructive market narrative around Pine Labs' medium-term financial performance.